InsidersTradesSigma
AstraZeneca PLC: directors' dealings · Finland · FIN-FSA
FI:astrazeneca-plc-c09efbGB0009895292FI·FIN-FSAMcap 212.6Bn€Healthcare
Explore the full management transaction log of AstraZeneca PLC, a listed equity based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, AstraZeneca PLC has published 7 public disclosures. Market capitalisation: €212.6bn. The latest transaction was reported on 21 May 2026 — Purchase. Among the most active insiders: Pascal Soriot. All data is openly available.
7
Insider Decl.
0
Thresholds
€735
2 ops.
Buy Volume
€1m
2 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
13710.00 €
Analyst consensus
21 analystsBuy
11465.22 €Target 16507.58 €(+20%)18807.37 €
Income statement
Revenue58.74 Bn€
Gross profit48.11 Bn€82% margin
Net income10.22 Bn€17.2% margin
Valuation
PER (trailing)27.9x
PER (forward)1181.0x
P/Book609.9x
Beta0.22
Balance sheet & cash
Market cap212.62 Bn€
Total debt29.15 Bn€
Free Cash Flow8.67 Bn€
Debt / Equity72%
Profitability & ownership
ROE23.5%
ROA8.5%
% insiders0.0%
% institutions63.0%
Last declaration on 21 May 2026
Declarations7 total
Executives●Purchase0RNS
18,359 shares
Outside a trading venue
RNS:9573813·
Ideal exit: 8 Feb 2027 (T+270)
Executives●Sale20FIN-FSA
€40,083297 shares@ €134.960.0000% mcap100.0% of flow
Aktie
FI:A003U931-1·
Executives●Sale39FIN-FSA
€1m15,000 shares@ €88.63450.0006% mcap100.0% of flow
Depåbevis
FI:A003T664-1·
Executives●Other38FIN-FSA
0136,537 shares0
Aktie
FI:A003T466-1·
Executives●Purchase20FIN-FSA
€7359.074 shares@ €81.04990.0000% mcap100.0% of flow
Depåbevis
FI:A003S640-1·
Ideal exit: 6 Jun 2026 (T+270)
7 of 7 declarations